Typicality: | 0.347 |
Saliency: | 0.228 |
since 1995 | 3 | temporal |
for rotavirus | 2 | purpose |
vaccine → be approved in → the united states | 12 |
vaccine → be approved in → the us | 4 |
negative | neutral | positive |
0.081 | 0.529 | 0.389 |
Raw frequency | 16 |
Normalized frequency | 0.228 |
Modifier score | 0.500 |
Perplexity | 23.129 |